David Liston

David Liston

Company: ReCode Therapeutics

Job title: Senior Scientist

Bio:

Seminar: Bioanalytical Strategies to Evaluate the Efficacy, Biodistribution, & Tolerability of an Inhaled mRNA Therapy

  • How to characterize efficacy and cell type specific targeting in primary cell-based disease
    models and translation to preclinical animal models
  • Biodistribution of mRNA, LNP components, and target protein expression in preclinical models
  • Methods to assess tolerability of mRNA therapeutics

Day: Pre-Conference Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.